Please use this identifier to cite or link to this item:
http://repo.tma.uz/xmlui/handle/1/1788
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Akramova N.T., Nabiyeva D. A., Bobomurodov T.A., Bobomurodova D.T. | - |
dc.date.accessioned | 2025-06-05T12:57:07Z | - |
dc.date.available | 2025-06-05T12:57:07Z | - |
dc.date.issued | 2025 | - |
dc.identifier.uri | http://repo.tma.uz/xmlui/handle/1/1788 | - |
dc.description.abstract | Maqsad: podagra bilan og’rigan bemorlarda MTH FR C677T (A223V), PAI-1 675 4G/5G polimorfizmlarini aniqlash. Material va usullar: podagra bilan og’rigan 98 bemor tekshirildi. Venoz qondagi yadroli hujayralar massasi eritrotsitlarni 5,0 ml li probirkalarda maxsus fiziologik eritma (NH4 Cl, KHCO3 va EDTA) bilan qonga nis bati 1: 3 bo’lgan eritrotsitlar lizisi bilan ajratilgan. Xona haroratida 10 daqiqa davomida inkubatsiya qilingandan so’ng, naychalar 5 daqiqa davomida 3000 rpm tezlikda sentrifugalanadi. Natijalar: MTHFR C677T (A223V) va PAI-1 675 4G/5G gen polimorfizmlarini o’rganish shuni ko’rsatdiki, ko’pchilik bemorlarda tromboz va yurak-qon tomir kasalliklari xavfini oshirishi mumkin bo’lgan gene tik o’zgarishlar mavjud. Xulosa: podagra bilan og’rigan bemorlarda gemostazning genetik tahlili zarur. | en_US |
dc.language.iso | other | en_US |
dc.publisher | O'zbekiston, Toshkent | en_US |
dc.relation.ispartofseries | UDK;616.72-002:616.13-005.3:575.113 | - |
dc.subject | podagra, gemostaz, molekulyar-genetik polimorfizm, MTHFR C677T, PAI-1 675 4G/5G, giperurike miya, tromboz, yurak-qon tomir kasalliklari. | en_US |
dc.title | PODAGRA BILAN HASTALANGAN BEMORLARDA GEMOSTAZ TIZIMIDAGI MOLEKULYAR GENETIK POLIMORFIZMLAR | en_US |
dc.type | Article | en_US |
Appears in Collections: | Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
4 2025 в печать (1).pdf | PODAGRA BILAN HASTALANGAN BEMORLARDA GEMOSTAZ TIZIMIDAGI MOLEKULYAR GENETIK POLIMORFIZMLAR | 1.21 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.